267 related articles for article (PubMed ID: 29732051)
1. Dual-targeting biomimetic delivery for anti-glioma activity
Zhao P; Wang Y; Kang X; Wu A; Yin W; Tang Y; Wang J; Zhang M; Duan Y; Huang Y
Chem Sci; 2018 Mar; 9(10):2674-2689. PubMed ID: 29732051
[TBL] [Abstract][Full Text] [Related]
2. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
[TBL] [Abstract][Full Text] [Related]
3. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
[TBL] [Abstract][Full Text] [Related]
4. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery.
Zheng Z; Zhang J; Jiang J; He Y; Zhang W; Mo X; Kang X; Xu Q; Wang B; Huang Y
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817393
[TBL] [Abstract][Full Text] [Related]
5. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
[TBL] [Abstract][Full Text] [Related]
6. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
7. Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide.
Mo X; Zheng Z; He Y; Zhong H; Kang X; Shi M; Liu T; Jiao Z; Huang Y
J Control Release; 2018 Oct; 287():12-23. PubMed ID: 30096402
[TBL] [Abstract][Full Text] [Related]
8. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
9. Brain-targeting biomimetic nanoparticles for codelivery of celastrol and LY2157299 for reversing glioma immunosuppression.
Zhu S; Sun F; Zhao P; Liang G; Sun X; Zeng L; Huang Y
Int J Pharm; 2022 May; 619():121709. PubMed ID: 35364220
[TBL] [Abstract][Full Text] [Related]
10. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery.
Chen B; Gao A; Tu B; Wang Y; Yu X; Wang Y; Xiu Y; Wang B; Wan Y; Huang Y
Biomaterials; 2020 Oct; 255():120187. PubMed ID: 32590192
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1.
Wang H; Tang Y; Fang Y; Zhang M; Wang H; He Z; Wang B; Xu Q; Huang Y
Nano Lett; 2019 May; 19(5):2935-2944. PubMed ID: 30950276
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
13. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
14. TfR-T12 short peptide and pH sensitive cell transmembrane peptide modified nano-composite micelles for glioma treatment via remodeling tumor microenvironment.
Sun P; Wu Z; Xiao Y; Wu H; Di Q; Zhao X; Quan J; Tang H; Wang Q; Chen W
Nanomedicine; 2022 Apr; 41():102516. PubMed ID: 35131469
[TBL] [Abstract][Full Text] [Related]
15. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
[TBL] [Abstract][Full Text] [Related]
16. Mannose and Hyaluronic Acid Dual-Modified Iron Oxide Enhances Neoantigen-Based Peptide Vaccine Therapy by Polarizing Tumor-Associated Macrophages.
Nie Y; Shi L; Zhang Y; Guo Y; Gu H
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291890
[TBL] [Abstract][Full Text] [Related]
17. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.
Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D
Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy.
Wang R; Song W; Zhu J; Shao X; Yang C; Xiong W; Wang B; Zhao P; Chen M; Huang Y
J Control Release; 2024 Apr; 368():84-96. PubMed ID: 38331004
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
20. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
